Evidence map›Paper›PMID 24739493›Full record

ReviewCurrent opinion in pediatrics2014

Recent evidence on the management of bronchiolitis.

Alan R Schroeder, Jonathan M Mansbach

Abstract readReview
In one paragraph

Review in Current opinion in pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. [Expression of vascular intercellular adhesion molecule-1 and its significance in children with bronchiolitis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Alan R SchroederaDepartment of Pediatrics, Santa Clara Valley Medical Center, San Jose, California bDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jonathan M Mansbach
Boston Children's Hospital · USSanta Clara Valley Medical Center · US

Funding

Prospective Cohort Study of Severe Bronchiolitis and Risk of Recurrent WheezingU01AI087881 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CAMARGO, CARLOS ARTURO · 2011 to 2016
$6.2M
Prospective Multicenter Study of Bronchiolitis Admissions: Etiology & DispositionU01AI067693 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CAMARGO, CARLOS ARTURO · 2007 to 2010
$3.6M
Vitamin D deficiency and the severity of bronchiolitisK23AI077801 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MANSBACH, JONATHAN M · 2009 to 2012
$617k
NIAID NIH HHS K23 AI077801NIAID NIH HHS K23 AI-77801NIAID NIH HHS U01 AI067693NIAID NIH HHS U01 AI087881NIAID NIH HHS U01 AI-67693
6 · The paper itself

Abstract

purpose of reviewBronchiolitis is a common condition in children less than 2  years of age and is a leading cause of infant hospitalization. Although there is significant variability in testing and treatment of children with bronchiolitis, diagnostic testing rarely improves care, and no currently available pharmacologic options have been proven to provide meaningful benefits or improve outcomes. RECENT

findingsBeta-agonists continue to be used frequently despite evidence that they do not reduce hospital admissions or length of stay. In general, therapies initially considered promising were subsequently proven ineffective, a pattern seen in studies on corticosteroids, and more recently with nebulized racemic epinephrine and hypertonic saline. Recent research has improved our understanding of the viral epidemiology of bronchiolitis, with increasing recognition of viruses other than respiratory syncytial virus and better awareness of the role of viral coinfections. How these findings will translate into improved outcomes remains uncertain. SUMMARY: Much of the emphasis of the last few decades of bronchiolitis clinical care and research has centered on the identification and testing of novel therapies. Future quality improvement efforts should focus more on the limitation of unnecessary testing and treatments. Future research should include identification of subgroups of children with bronchiolitis that may benefit from focused clinical interventions.

Indexed as

BronchiolitisBronchodilator AgentsChildChild, PreschoolEpinephrineGlucocorticoidsHospitalizationHumansInfantInfant, NewbornLength of StayRespiratory Syncytial VirusesRespiratory Syncytial Virus InfectionsSaline Solution, HypertonicSeverity of Illness IndexTreatment OutcomeBronchodilator AgentsEpinephrineGlucocorticoidsSaline Solution, Hypertonic

Identifiers

PMID24739493
PMCPMC4552182
OpenAlexW2082221382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.